AASLD/EASL HBV Endpoints Conference

CME

Advertisement

This conference brings together the academic, regulatory, pharmaceutical communities to discuss therapeutic endpoints, trial designs, appropriate patient populations and safety concerns with regards to novel therapeutic approaches for the treatment of chronic hepatitis B and D.

8.75 AMA PRA Category 1 Credits™ - maximum

8.75 ABIM MOC points

Venue: Washington Marriott at Metro Center

Date

June 3-4, 2022

Location

Washington, D.C. 20005, United States

Email

meetings@aasld.org

Website

www.aasld.org/event/2022-aasldeasl-hbv-endpoints-conference/

Advertisement